Glucagon-like peptide-1 receptor agonist activation ameliorates venous thrombosis- induced arteriovenous fistula failure in chronic kidney d isease

Thrombosis and Haemostasis

Volumn 112, Issue 5, 2013, Pages 1051-1064

  Chien, Chiang Ting ^c   Fan, Shih Chen ^a   Lin, Shao Chieh ^e   Kuo, Chang Chih ^b   Yang, Chih Hui ^a   Yu, Tzu Ying ^a   Lee, Shih Pin ^c   Cheng, Dai Yu ^d   Li, Ping Chia ^a  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^d Ta Tung University   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Free radicals; Glucagon like peptide 1; Peripheral vascular disease; Thrombosis

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXENDIN 4; HEME OXYGENASE 1; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2; THROMBOXANE B2; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HMOX1 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; PEPTIDE; VENOM;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD FLOW; CELL INFILTRATION; CELL PROLIFERATION; CELL STRUCTURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENE DELETION; GENE EXPRESSION; MALE; NONHUMAN; RAT; SENESCENCE; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOSIS; UMBILICAL VEIN ENDOTHELIAL CELL; VEIN ANASTOMOSIS; VEIN THROMBOSIS; ADVERSE EFFECTS; AGONISTS; ANASTOMOSIS; ANIMAL; ARTERIOVENOUS SHUNT; BIOSYNTHESIS; CELL ADHESION; CELL AGING; COMMON CAROTID ARTERY; DRUG EFFECTS; GENETICS; HUMAN; JUGULAR VEIN; MOUSE; PATHOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SURGERY; VASCULAR ENDOTHELIUM; VENOUS THROMBOSIS; WISTAR RAT;

ANASTOMOSIS, SURGICAL; ANIMALS; APOPTOSIS; ARTERIOVENOUS SHUNT, SURGICAL; CAROTID ARTERY, COMMON; CELL ADHESION; CELL AGING; ENDOTHELIUM, VASCULAR; HEME OXYGENASE-1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; JUGULAR VEINS; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; RENAL INSUFFICIENCY, CHRONIC; THROMBOXANE A2; VENOMS; VENOUS THROMBOSIS;

EID: 84908501502     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-03-0258     Document Type: Article

References (50)

1. Anwar MA, Shalhoub J, Lim CS, et al. The effect of pressure-induced mechanical stretch on vascular wall differential gene expression. J Vasc Res 2012; 49: 463-478.
2. Tsapenko MV, d'Uscio LV, Grande JP, et al. Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula. Am J Physiol Renal Physiol 2012; 303: F1601-1607.
3. Croatt AJ, Grande JP, Hernandez MC, et al. Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol 2010; 176: 2530-2541.
4. Oeseburg H, de Boer RA, Buikema H, et al. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol 2010; 30: 1407-1414.
5. Hoffmann J, Haendeler J, Aicher A, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001; 89: 709-715.
6. Uraoka M, Ikeda K, Kurimoto-Nakano R, et al. Loss of bcl-2 during the senescence exacerbates the impaired angiogenic functions in endothelial cells by deteriorating the mitochondrial redox state. Hypertension 2011; 58: 254-263.
7. Karamouzis I, Grekas D, Karamouzis M, et al. Physical training in patients on hemodialysis has a beneficial effect on the levels of eicosanoid hormone-like substances. Hormones 2009; 8: 129-137.
8. Smyth EM. Thromboxane and the thromboxane receptor in cardiovascular disease. Clin Lipidol 2010; 5: 209-219.
9. Zhang M, Song P, Xu J, et al. Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol 2011; 31: 125-132.
10. Siangjong L, Gauthier KM, Pfister SL, et al. Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries. Am J Physiol Heart Circ Physiol 2013; 304: H382-392.
11. Yoo HV, Oark SJ, Seo EY, et al. Role of thromboxane A2-activated nonselective cation channels in hypoxic pulmonary vasoconstriction of rat. Am J Physiol Cell Physiol 2012; 302: C307-317.
12. Dember LM, Beck GJ, Allon M, et al. Dialysis Access Consortium Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. J Am Med Assoc 2008; 299: 2164-2171.
13. Roan JN, Fang SY, Chang SW, et al. Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model. J Vasc Surg 2012; 56: 1381-1389.
14. Donnelly D. The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br J Pharmacol 2012; 166: 27-41.
15. Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 2007; 113: 546-593.
16. Kielgast U, Holst JJ, Madsbad S. Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists. Curr Diabetes Rev 2009; 5: 266-275.
17. Noyan-Ashraf MH, Momen MA, Ban K, et al. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 2009; 58: 975-983.
18. Nystrom T, Gutniak MK, Zhang Q, et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab 2004; 287: E1209-1215.
19. Xie Y, Wang SX, Sha WW, et al. Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation. Chin Med J 2008; 121: 2134-2138.
20. Shiraki A, Oyama JI, Komoda H, et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-alpha-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis 2012; 221: 375-382.
21. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131-2157.
22. Thum A, Hupe-Sodmann K, Goke R, et al. Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and-4. Exp Clin Endocrinol Diabetes 2001; 110: 113-118.
23. Chen J, Couto FM, Minn AH, et al. Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein. Biochem Biophys Res Commun 2006; 346: 1067-1074.
24. Li Y, Hansotia T, Yusta B, et al. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 2003; 278: 471-478.
25. Ferdaoussi M, Abdelli S, Yang JY, et al. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-jun nh2-terminal kinase pathway. Diabetes 2008; 57: 1205-1215.
26. Choi SE, Min SH, Shin HC, et al. Involvement of calcium-mediated apoptotic signals in H2O2-induced MIN6N8a cell death. Eur J Pharmacol 2006; 547: 1-9.
27. Lei X, Reheman A, Hou Y, et al. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thromb Haemost 2014; 111: 279-289.
28. Berdeaux O, Chardigny JM, Sébédio JL, et al. Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production. J Lipid Res 1996; 37: 2244-2250.
29. Akishita M, Nagai K, Xi H, et al. Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats. Hypertension 2005; 45: 1188-1193.
30. Noyan-Ashraf MH, Shikatani EA, Schuiki I, et al. A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 2013; 127: 74-85.
31. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001; 88: 877-887.
32. Ban K, Noyan-Ashraf MH, Hoefer J, et al. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagonlike peptide 1 receptor-dependent and-independent pathways. Circulation 2008; 117: 2340-2350.
33. Green BD, Hand KV, Dougan JE, et al. GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP. Arch Biochem Biophys 2008; 478: 136-142.
34. Cabou C, Campistron G, Marsollier N, et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008; 57: 2577-2587.
35. Shan HY, Bai XJ, Chen XM. Apoptosis is involved in the senescence of endothelial cells induced by angiotensin II. Cell Biol Int 2008; 32: 264-270.
36. Naranmandura H, Chen X, Tanaka M, et al. Release of apoptotic cytochrome C from mitochondria by dimethylarsinous acid occurs through interaction with voltage-dependent anion channel in vitro. Toxicol Sci 2012; 128: 137-146.
37. Arbel N, Shoshan-Barmatz V. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity. J Biol Chem 2010; 285: 6053-6062.
38. Chien CT, Chang TC, Tsai CY, et al. Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis. Am J Transplant 2005; 5: 1194-1203.
39. Flores-Delgado G, Liu CWY, Sposto R, et al. A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis. J Proteome Res 2007; 6: 1165-1175.
40. Martin D, Salinas M, Fujita N, et al. Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem 2002; 277: 42943-42952.
41. Li PC, Yang CC, Hsu SP, et al. Repetitive progressive thermal preconditioning hinders thrombosis by reinforcing phosphatidylinositol 3-kinase/Akt-dependent heat-shock protein/endothelial nitric oxide synthase signaling. J Vasc Surg 2012; 56: 159-170.
42. Salinas M, Wang J, de Sagarra MR, et al. Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett 2004; 578: 90-94.
43. Deng X, Gao F, May WS Jr. Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 2003; 102: 3179-3185.
44. Erdogdu O, Nathanson D, Sjoholm A, et al. Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA-and PI3K/Akt-dependent pathways and requires GLP-1 receptor. Mol Cell Endocrinol 2010; 325: 26-35.
45. Kimura R, Okouchi M, Fujioka H, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced pc12 cell apoptosis through the PI3K/Akt/mTor/GCLC/redox signaling pathway. Neuroscience 2009; 162: 1212-1219.
46. Rücker M, Laschke MW, Stamm A, et al. Local preconditioning by thermal stress accelerates microvascular thrombus formation. Shock 2009; 31: 627-633.
47. Falk E. Thrombosis in unstable angina: pathologic aspects. In: Thrombosis and Platelets in Myocardial Ischemia. Philadelphia: F. A. Davis Publishers; 1987. pp. 137-149.
48. Lindenblatt N, Schareck W, Belusa L, et al. Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression. Thromb Haemost 2003; 90: 882-892.
49. Luo Z, Fujio Y, Kureishi Y, et al. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest 2000; 106: 493-499.
50. Maier JA, Bernardini D, Rayssiguier Y, et al. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta 2004; 1689: 6-12.